ATXI

Avenue Therapeutics, Inc. Common Stock
ATXI

Overview Fund Activity
Delisted

ATXI was delisted on the 18th of March, 2025.

Back to rankings

17 hedge funds and large institutions have $1.62M invested in Avenue Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 11 closing their positions.

Holders
17
Holders Change
-7
Holders Change %
-29.17%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
4
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Wells Fargo
1
Wells Fargo
California
$72K
2
Renaissance Technologies
2
Renaissance Technologies
New York
$176K
3
Citadel Advisors
3
Citadel Advisors
Florida
$41K
4
KAS
4
Kestra Advisory Services
Texas
$34K
5
TRCT
5
Tower Research Capital (TRC)
New York
$25K

Top Sellers

1
ASN
1
Advisory Services Network
Georgia
$0
2
E
2
Ergoteles
New York
$0
3
VF
3
Virtu Financial
New York
$0
4
Goldman Sachs
4
Goldman Sachs
New York
$0
5
BRWA
5
B. Riley Wealth Advisors
Florida
$133K
Name Holding Trade Value Shares
Change 		Shares
Change %
PPA
26
Parametric Portfolio Associates
Washington
– -$26K -9 Closed
Bank of America
27
Bank of America
North Carolina
– -$4K -2 Closed
JPMorgan Chase & Co
28
JPMorgan Chase & Co
New York
– -$2K -1 Closed
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
– -$3K -1 Closed
1
2